Document is current
Any future updates will be listed below
-
Authors
Hajam, Irshad A.
Katiki, Madhusudhanarao
McNally, Randall
Lázaro-Díez, María http://orcid.org/0000-0002-6098-8052
Kolar, Stacey
Chatterjee, Avradip http://orcid.org/0000-0001-8345-4339
Gonzalez, Cesia
Paulchakrabarti, Mousumi
Choudhury, Biswa
Caldera, J. R. http://orcid.org/0000-0003-0563-8815
Desmond, Trieu
Tsai, Chih-Ming
Du, Xin http://orcid.org/0000-0002-6907-3609
Li, Huiying
Murali, Ramachandran http://orcid.org/0000-0002-8384-2793
Liu, George Y. http://orcid.org/0000-0003-0759-0587
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01AI141401, R21AI127406)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
- License Information
-
More Information
Article History
Received: 6 April 2023
Accepted: 21 November 2023
First Online: 5 December 2023
Competing interests
: R.M., G.Y.L., I.A.H. and S.K. have filed for a patent application for the use of selective HylA inhibitors and vaccines as therapeutics. The remaining authors declare no competing interests.
